Strategy of the Global Leader in Rare Disease Drugs with Scott Pescatore Recordati
Release Date: 12/11/2025
Virtual Support Groups Remove Barriers Encourage Sharing Honest Experiences to Fight Misinformation with Rick Davis AnCan TRANSCRIPT
Empowered Patient Podcast
Rick Davis, patient advocate and Founder of AnCan, is building and operating virtual peer-to-peer support groups to allow patients to connect with others who have direct experience with their condition. These groups can provide accurate information, foster connections among participants, and serve as a check on medical misinformation. With the growing acceptance of virtual meetings, this approach overcomes geographic, physical, and psychosocial barriers that might otherwise prevent participants from attending on-site meetings. Rick explains, "The mission is to make each person and each...
info_outline
Virtual Support Groups Remove Barriers Encourage Sharing Honest Experiences to Fight Misinformation with Rick Davis AnCan
Empowered Patient Podcast
Rick Davis, patient advocate and Founder of AnCan, is building and operating virtual peer-to-peer support groups to allow patients to connect with others who have direct experience with their condition. These groups can provide accurate information, foster connections among participants, and serve as a check on medical misinformation. With the growing acceptance of virtual meetings, this approach overcomes geographic, physical, and psychosocial barriers that might otherwise prevent participants from attending on-site meetings. Rick explains, "The mission is to make each person and each...
info_outline
Healthcare Plans Using Analytics to Improve Health Literacy Patient Engagement and Outcomes with Bob Farrell mPulse TRANSCRIPT
Empowered Patient Podcast
Bob Farrell, CEO of mPulse, is using digital technology, data analytics and AI to improve the relationship between health plans and their members in order to improve health outcomes and operational efficiency. Bob introduces the concept of HXI, Health Experience and Insights, as a framework that unites data, intelligence, and personalized communication to provide tools to enage members at the best time and by the preferred methods with appropriate information at the right time. Analyzing claims data enables plans to identify high-risk patients, promote preventive care, and build health...
info_outline
Healthcare Plans Using Analytics to Improve Health Literacy Patient Engagement and Outcomes with Bob Farrell mPulse
Empowered Patient Podcast
Bob Farrell, CEO of mPulse, is using digital technology, data analytics and AI to improve the relationship between health plans and their members in order to improve health outcomes and operational efficiency. Bob introduces the concept of HXI, Health Experience and Insights, as a framework that unites data, intelligence, and personalized communication to provide tools to enage members at the best time and by the preferred methods with appropriate information at the right time. Analyzing claims data enables plans to identify high-risk patients, promote preventive care, and build health...
info_outline
AI-Powered Drug Discovery Platform Transforms Broad Antiviral Development with Rick Pierce Decoy Therapeutics TRANSCRIPT
Empowered Patient Podcast
Rick Pierce, Co-Founder and CEO of Decoy Therapeutics. is using AI and machine learning to accelerate drug discovery and is developing broad-acting antivirals using peptide conjugates that target a shared invasion mechanism of hundreds of viruses. The company is using small language models and a high-speed peptide synthesizer to dramatically reduce drug creation time. Rick predicts that the future of drug discovery will combine AI-driven design with advanced biological models, such as organoids, to better predict drug toxicity and efficacy. Rick explains, "Decoy Therapeutics was founded...
info_outline
AI-Powered Drug Discovery Platform Transforms Broad Antiviral Development with Rick Pierce Decoy Therapeutics
Empowered Patient Podcast
Rick Pierce, Co-Founder and CEO of Decoy Therapeutics. is using AI and machine learning to accelerate drug discovery and is developing broad-acting antivirals using peptide conjugates that target a shared invasion mechanism of hundreds of viruses. The company is using small language models and a high-speed peptide synthesizer to dramatically reduce drug creation time. Rick predicts that the future of drug discovery will combine AI-driven design with advanced biological models, such as organoids, to better predict drug toxicity and efficacy. Rick explains, "Decoy Therapeutics was founded...
info_outline
Concierge Healthcare Services for Employees of Self-Insured Companies with Dr. Kumar Dharmarajan World Class Health TRANSCRIPT
Empowered Patient Podcast
Dr. Kumar Dharmarajan, cardiologist and geriatrician and Co-Founder and Chief Medical Officer at World Class Health, is bringing concierge healthcare to employees of self-insured companies. The platform includes a global network of top-tier doctors and nurse navigators. Directly negotiating with providers reduces costs and reduces administrative and financial friction for patients seeking planned procedures. The model also reduces friction for physicians by providing them with complete patient records and ensuring prompt payment. Kumar explains, "We are a global,...
info_outline
Concierge Healthcare Services for Employees of Self-Insured Companies with Dr. Kumar Dharmarajan World Class Health
Empowered Patient Podcast
Dr. Kumar Dharmarajan, cardiologist and geriatrician and Co-Founder and Chief Medical Officer at World Class Health, is bringing concierge healthcare to employees of self-insured companies. The platform includes a global network of top-tier doctors and nurse navigators. Directly negotiating with providers reduces costs and reduces administrative and financial friction for patients seeking planned procedures. The model also reduces friction for physicians by providing them with complete patient records and ensuring prompt payment. Kumar explains, "We are a global,...
info_outline
Direct-to-Consumer Health Tools and AI Making Medical Information Accessible with Brent Dial Beek Health TRANSCRIPT
Empowered Patient Podcast
Brent Dial, Founder and CEO of Beek Health, has built a platform that addresses patient information fragmentation by aggregating data from patient portals and providing direct access to lab testing. Health literacy is key to preventing chronic diseases, and AI is being used to scale the delivery of personalized health information. Identifying relevant biomarkers and early warning signs supports proactive health management that can alter long-term health outcomes. Brent explains, "Beek Health is re-imagining healthcare by finally putting the individual at the center of their health journey....
info_outline
Direct-to-Consumer Health Tools and AI Making Medical Information Accessible with Brent Dial Beek Health
Empowered Patient Podcast
Brent Dial, Founder and CEO of Beek Health, has built a platform that addresses patient information fragmentation by aggregating data from patient portals and providing direct access to lab testing. Health literacy is key to preventing chronic diseases, and AI is being used to scale the delivery of personalized health information. Identifying relevant biomarkers and early warning signs supports proactive health management that can alter long-term health outcomes. Brent explains, "Beek Health is re-imagining healthcare by finally putting the individual at the center of their health journey....
info_outlineScott Pescatore, Executive VP of the Rare Diseases Business at Recordati, is focused on rare and ultra-orphan diseases with high unmet needs by acquiring promising compounds from other companies and advancing them through development and approval. An example is the company's drug Isturisa, acquired from Novartis, which is an FDA-approved effective treatment for patients with Cushing syndrome, a rare endocrine condition. Raising awareness of rare diseases among physicians, patients, and the general public is a priority for Recordati to improve diagnosis rates and clinical trial participation, and to encourage more research and funding in the rare disease space.
Scott explains, "We have two primary divisions at Recordati. One is our specialty primary care business, and the other is the rare disease business, which I have the honor and privilege to look after. And we have a very simple sort of work ethic or business mantra, if you will, and that's focused on the few. And we really dedicate ourselves to focusing on disease areas and patient groups and therapeutic areas that have a high unmet need and really low or limited options for patients. And really focusing on diseases and areas that are rare and considered ultra-orphan by the definitions in the US, where really there's a very small patient base. And that's where we began back in 2007, when the rare disease business was formed. And that's really what our focus has been since then. And we continue to focus on this segment of the market."
"So Isturisa is really a fantastic product. We acquired this product through a deal we did with Novartis Pharmaceuticals back in 2019, and this product has FDA approval for patients who have endogenous hypercortisolemia with Cushing syndrome. So it's quite a nasty disease, but it's a very efficacious product. The product is what's considered a cortisol inhibitor in the blocks in a particular enzyme to help normalize hypercortisolemia in patients with Cushing syndrome. And Cushing syndrome, for those who aren't familiar, is a rare endocrine condition that really has a significant impact on patients' quality of life, on the caregivers, on the families. And the indication I mentioned was supported by quite robust phase 3 trials."
#Recordati #RareDisease #FocusedontheFew #CushingSyndrome #IMCD #CastlemansDisease
